180 related articles for article (PubMed ID: 1666894)
21. [Proteolytic enzymes and the destruction of articular cartilage in arthritis and chronic polyarthritis].
Mohamed-Ali H
Wien Med Wochenschr; 1991; 141(4):77-85. PubMed ID: 1645488
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1.
Dodge GR; Poole AR
J Clin Invest; 1989 Feb; 83(2):647-61. PubMed ID: 2783591
[TBL] [Abstract][Full Text] [Related]
23. Effects of the hydroxamic acid derivate Ro 31-4724 on the metabolism and morphology of interleukin-1-treated cartilage explants.
Steinmeyer J; Daufeldt S; Kalbhen DA
Pharmacology; 1997 Aug; 55(2):95-108. PubMed ID: 9323309
[TBL] [Abstract][Full Text] [Related]
24. Investigation of the role of metalloproteinases in recombinant human interleukin-1 beta-induced degradation of rat femoral head cartilage.
Seed MP; Thomson TA; Gardner CR
Drugs Exp Clin Res; 1991; 17(7):355-61. PubMed ID: 1794302
[TBL] [Abstract][Full Text] [Related]
25. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
[TBL] [Abstract][Full Text] [Related]
26. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures.
Kozaci LD; Buttle DJ; Hollander AP
Arthritis Rheum; 1997 Jan; 40(1):164-74. PubMed ID: 9008612
[TBL] [Abstract][Full Text] [Related]
27. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
[TBL] [Abstract][Full Text] [Related]
28. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines.
Patwari P; Cook MN; DiMicco MA; Blake SM; James IE; Kumar S; Cole AA; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2003 May; 48(5):1292-301. PubMed ID: 12746902
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis.
Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS
Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343
[TBL] [Abstract][Full Text] [Related]
30. Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown.
Shingleton WD; Ellis AJ; Rowan AD; Cawston TE
J Cell Biochem; 2000 Sep; 79(4):519-31. PubMed ID: 10996843
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.
Esser CK; Bugianesi RL; Caldwell CG; Chapman KT; Durette PL; Girotra NN; Kopka IE; Lanza TJ; Levorse DA; MacCoss M; Owens KA; Ponpipom MM; Simeone JP; Harrison RK; Niedzwiecki L; Becker JW; Marcy AI; Axel MG; Christen AJ; McDonnell J; Moore VL; Olszewski JM; Saphos C; Visco DM; Hagmann WK
J Med Chem; 1997 Mar; 40(6):1026-40. PubMed ID: 9083493
[TBL] [Abstract][Full Text] [Related]
32. Gelatinase is the main matrix metalloproteinase involved in granuloma-induced cartilage degradation.
Trancart MM; Chalmeigne N; Girardot C; Zarpanelian C; Prigent D
Int J Tissue React; 1992; 14(6):287-94. PubMed ID: 1339118
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes.
Hui A; Min WX; Tang J; Cruz TF
Arthritis Rheum; 1998 May; 41(5):869-76. PubMed ID: 9588740
[TBL] [Abstract][Full Text] [Related]
34. Primary structure and function of stromelysin/transin in cartilage matrix turnover.
Wilhelm SM; Wunderlich D; Maniglia CA; Eisen AZ; Goldberg GI
Matrix Suppl; 1992; 1():37-44. PubMed ID: 1480063
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors.
Bottomley KM; Borkakoti N; Bradshaw D; Brown PA; Broadhurst MJ; Budd JM; Elliott L; Eyers P; Hallam TJ; Handa BK; Hill CH; James M; Lahm HW; Lawton G; Merritt JE; Nixon JS; Röthlisberger U; Whittle A; Johnson WH
Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):483-8. PubMed ID: 9163342
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine.
Badger AM; Cook MN; Swift BA; Newman-Tarr TM; Gowen M; Lark M
J Pharmacol Exp Ther; 1999 Aug; 290(2):587-93. PubMed ID: 10411566
[TBL] [Abstract][Full Text] [Related]
37. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis.
Xie DL; Hui F; Meyers R; Homandberg GA
Arch Biochem Biophys; 1994 Jun; 311(2):205-12. PubMed ID: 8203882
[TBL] [Abstract][Full Text] [Related]
38. Differential induction of stromelysin mRNA by bovine articular chondrocytes treated with interferon-gamma and interleukin-1 alpha.
Quintavalla JC; Berg RA; Beavis AJ; Piccoli SP; Rediske JJ; Kurkinen M; Patrick RA; Robertson FM
J Cell Physiol; 1993 Jan; 154(1):113-21. PubMed ID: 8419398
[TBL] [Abstract][Full Text] [Related]
39. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
40. Modulation of the catabolic effects of interleukin-1 beta on human articular chondrocytes by transforming growth factor-beta.
Lum ZP; Hakala BE; Mort JS; Recklies AD
J Cell Physiol; 1996 Feb; 166(2):351-9. PubMed ID: 8591995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
